Results from five clinical trials were presented during the VIVA (Vascular InterVentional Advances) Conference, VIVA23, providing outcomes from studies on treatment for chronic limb-threatening ischemia (CLTI), use of drug-coated balloons, among other highly-anticipated late-breaking science findings.
/PRNewswire/ The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and.
First Round of Late-Breaking Clinical Trial Results Announced at VIVA23 kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
The AHA calls for individualizing PAD care through patient-reported outcome measures and developing metrics to ensure high-quality care that could be tied to reimbursement.